Apr 18 |
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
|
Apr 10 |
Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains
|
Apr 4 |
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
|
Apr 4 |
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
|
Apr 3 |
Arbutus Biopharma jumps after claim construction order in patent fight with Moderna
|
Apr 1 |
Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans?
|
Mar 8 |
Arbutus to Participate in Two Upcoming Investor Conferences
|
Mar 3 |
Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
|
Mar 2 |
Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue Forecasts
|
Mar 1 |
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
|